Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.

作者: Jiri Sana , Petr Busek , Pavel Fadrus , Andrej Besse , Lenka Radova

DOI: 10.1038/S41598-018-20929-6

关键词:

摘要: Glioblastoma stem-like cells (GSCs) are critical for the aggressiveness and progression of glioblastoma (GBM) contribute to its resistance adjuvant treatment. MicroRNAs (miRNAs) small, non-coding RNAs controlling gene expression at post-transcriptional level, which known be important regulators features. Moreover, miRNAs have been previously proved promising diagnostic biomarkers in several cancers including GBM. Using global analysis 10 paired in-vitro as well in-vivo characterized primary GSC non-stem cultures, we identified a miRNA signature associated with phenotype 51 most deregulated classified cell cultures into clusters subgroup more pronounced stem-cell characteristics. The importance was further supported by demonstrating that Risk Score based on seven overexpressed predicted overall survival GBM patients TCGA dataset independently IDH1 status. In summary, differentially expressed GSCs described their association patient survival. We propose these participate features could represent helpful prognostic markers potential therapeutic targets

参考文章(61)
Wei Zhang, Huanran Chen, Shengqing Lv, Hui Yang, High CD133 Expression Is Associated with Worse Prognosis in Patients with Glioblastoma. Molecular Neurobiology. ,vol. 53, pp. 2354- 2360 ,(2016) , 10.1007/S12035-015-9187-1
Rikke H Dahlrot, Henrik D Schrøder, Bjarne W Kristensen, Stine S Jensen, Jacob Hjelmborg, Steinbjørn Hansen, Clinical value of CD133 and nestin in patients with glioma: a population-based study International Journal of Clinical and Experimental Pathology. ,vol. 7, pp. 3739- 3751 ,(2014)
G. K. Smyth, limma: Linear Models for Microarray Data Springer, New York, NY. pp. 397- 420 ,(2005) , 10.1007/0-387-29362-0_23
Terry M. Therneau, Patricia M. Grambsch, Modeling Survival Data: Extending the Cox Model ,(2000)
Renata Kleinová, Ondřej Slabý, Jiří Šáňa, The Relevance of MicroRNAs in Glioblastoma Stem Cells Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. ,vol. 28, pp. 338- 344 ,(2015) , 10.14735/AMKO2015338
Justin D. Lathia, Stephen C. Mack, Erin E. Mulkearns-Hubert, Claudia L.L. Valentim, Jeremy N. Rich, Cancer stem cells in glioblastoma Genes & Development. ,vol. 29, pp. 1203- 1217 ,(2015) , 10.1101/GAD.261982.115
Kyung-Jung Kim, Kyung-Hwa Lee, Hyung-Seok Kim, Kyung-Sub Moon, Tae-Young Jung, Shin Jung, Min-Cheol Lee, The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology. ,vol. 31, pp. 494- 502 ,(2011) , 10.1111/J.1440-1789.2010.01194.X
Gianfranca Miconi, Paola Palumbo, Soheila Raysi Dehcordi, Cristina La Torre, Francesca Lombardi, Zoran Evtoski, Anna Maria Cimini, Renato Galzio, Maria Grazia Cifone, Benedetta Cinque, Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome. Journal of Cellular Biochemistry. ,vol. 116, pp. 864- 876 ,(2015) , 10.1002/JCB.25043
Hong Wei Yang, Hongyan Xing, Mark D. Johnson, A major role for microRNAs in glioblastoma cancer stem-like cells Archives of Pharmacal Research. ,vol. 38, pp. 423- 434 ,(2015) , 10.1007/S12272-015-0574-Y
Mariana Lagos-Quintana, Reinhard Rauhut, Abdullah Yalcin, Jutta Meyer, Winfried Lendeckel, Thomas Tuschl, Identification of tissue-specific microRNAs from mouse Current Biology. ,vol. 12, pp. 735- 739 ,(2002) , 10.1016/S0960-9822(02)00809-6